Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-acetate Dihydrate
2. Mcn 2783-21-98
3. Zomax
4. Zomepirac
5. Zomepirac Potassium
1. Zomepirac Sodium Salt
2. 64092-48-4
3. Sodium Zomepirac
4. Zomepirac (sodium Salt)
5. Zomepirac Sodium Anhydrous
6. Sodium;2-[5-(4-chlorobenzoyl)-1,4-dimethylpyrrol-2-yl]acetate
7. Da5b6iwf46
8. Mcn-2783-21-98
9. 1h-pyrrole-2-acetic Acid, 5-(4-chlorobenzoyl)-1,4-dimethyl-, Sodium Salt
10. Ncgc00090751-01
11. Cas-64092-48-4
12. Dsstox_cid_13989
13. Dsstox_rid_79106
14. Dsstox_gsid_33989
15. Smr000686071
16. Mcn 2783-21-98
17. Ncgc00094811-01
18. Zomepiracsodiumsalt
19. Einecs 264-669-2
20. Unii-da5b6iwf46
21. Sodium 5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-acetate
22. 5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-acetic Acid Sodium Salt
23. Prestwick_973
24. Mls001055441
25. Mls002153996
26. Chembl266459
27. Dtxsid3033989
28. Schembl11172041
29. Zomepirac Sodium [who-dd]
30. Hms1570k20
31. Hms2097k20
32. Hms3714k20
33. Hy-b0890
34. Tox21_111006
35. Tox21_111335
36. Tox21_202177
37. Akos015962410
38. Tox21_111006_1
39. Ccg-220779
40. Cs-4353
41. Ncgc00017126-01
42. Ncgc00094811-06
43. Ncgc00259726-01
44. Ac-17496
45. Ft-0675929
46. Q27276294
47. Sodium [5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrol-2-yl]acetate
48. Sodium 2-(5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrol-2-yl)acetate
49. 1h-pyrrole-2-acetic Acid, 5-(4-chlorobenzoyl)-1,4-dimethyl-, Sodium Salt (1:1)
1. Zomepirac
| Molecular Weight | 313.71 g/mol |
|---|---|
| Molecular Formula | C15H13ClNNaO3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 313.0481653 g/mol |
| Monoisotopic Mass | 313.0481653 g/mol |
| Topological Polar Surface Area | 62.1 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 385 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
ABOUT THIS PAGE
60
PharmaCompass offers a list of Sodium Zomepirac API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Zomepirac manufacturer or Sodium Zomepirac supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Zomepirac manufacturer or Sodium Zomepirac supplier.
PharmaCompass also assists you with knowing the Sodium Zomepirac API Price utilized in the formulation of products. Sodium Zomepirac API Price is not always fixed or binding as the Sodium Zomepirac Price is obtained through a variety of data sources. The Sodium Zomepirac Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium Zomepirac manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Zomepirac, including repackagers and relabelers. The FDA regulates Sodium Zomepirac manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Zomepirac API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Zomepirac supplier is an individual or a company that provides Sodium Zomepirac active pharmaceutical ingredient (API) or Sodium Zomepirac finished formulations upon request. The Sodium Zomepirac suppliers may include Sodium Zomepirac API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Zomepirac suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Zomepirac DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Zomepirac active pharmaceutical ingredient (API) in detail. Different forms of Sodium Zomepirac DMFs exist exist since differing nations have different regulations, such as Sodium Zomepirac USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Zomepirac DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Zomepirac USDMF includes data on Sodium Zomepirac's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Zomepirac USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Zomepirac suppliers with USDMF on PharmaCompass.
Sodium Zomepirac Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Zomepirac GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Zomepirac GMP manufacturer or Sodium Zomepirac GMP API supplier for your needs.
A Sodium Zomepirac CoA (Certificate of Analysis) is a formal document that attests to Sodium Zomepirac's compliance with Sodium Zomepirac specifications and serves as a tool for batch-level quality control.
Sodium Zomepirac CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Zomepirac CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Zomepirac may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Zomepirac EP), Sodium Zomepirac JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Zomepirac USP).
